Corbus Pharmaceuticals announced today that the European Union they has approved orphan designation for lenabasum for the treatment of dermatomyositis.
Continue Reading
You may qualify for a research study
Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE). People diagnosed with lupus can sometimes also develop myositis, an inflammation of the skeletal muscles that causes weakness and loss of strength. Lupus myositis often affects the muscles of your neck, pelvis, thighs, shoulders, and upper arms. The Paisley Study…
Continue Reading
Overview of IBM diagnosis and potential treatments
A recent article in the journal Current Opinions in Rheumatology discusses significant points related to our current understanding about IBM diagnosis and potential treatments. Research has increased our understanding of the implications of the autoantibody anti-cytosolic 50-nucleotidase 1A (NT5C1A) as it relates to IBM. Muscle imaging using MRI and ultrasound is being performed more often,…
Continue Reading
If you have myositis and lupus, you may qualify for a research study
Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE).
Continue Reading
Statin use is associated with myositis
The use of statin medications is associated with the development of myositis, according to a new research study published in the July 30 issue of the journal JAMA Internal Medicine. The population-based study conducted in Australia showed a nearly twofold increase in statin exposure in patients with myositis compared with controls. Researchers also found an…
Continue Reading